Selective Janus kinase inhibitors: Promising drugs for rheumatoid arthritis

Natl Med J India. 2019 Mar-Apr;32(2):96-97. doi: 10.4103/0970-258X.275350.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents*
  • Arthritis, Rheumatoid*
  • Double-Blind Method
  • Heterocyclic Compounds, 3-Ring
  • Humans
  • Janus Kinase Inhibitors*

Substances

  • Antirheumatic Agents
  • Heterocyclic Compounds, 3-Ring
  • Janus Kinase Inhibitors
  • upadacitinib